+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

AI in MRI Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • TechSci Research
  • ID: 6051242
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global AI in MRI Market is projected to expand from USD 1.73 Billion in 2025 to USD 4.58 Billion by 2031, registering a CAGR of 17.62%. This sector encompasses machine learning and deep learning technologies integrated into magnetic resonance imaging workflows to automate image reconstruction and support diagnostic interpretation. Key drivers for this growth include the urgent need to shorten scan times for better patient throughput and the demand to alleviate radiologist burnout amidst rising caseloads. Evidence of this technological shift is found in recent data from the European Society of Radiology, which reported in 2024 that 48% of its surveyed members are currently utilizing AI tools in their clinical practice.

However, a major obstacle hindering market growth is the substantial capital investment needed for deployment. The high costs involved in acquiring software licenses and upgrading IT infrastructure present a significant barrier to entry, particularly for smaller independent clinics and healthcare systems in developing regions. As a result, budgetary limitations frequently compel facilities to postpone the implementation of these tools, despite the operational efficiencies they promise.

Market Drivers

A critical shortage of radiologists alongside surging imaging workloads is a primary force driving the adoption of AI in MRI. Healthcare systems are contending with a growing gap between the volume of necessary diagnostic scans and the workforce available to interpret them, necessitating automated solutions to prevent burnout and delays in diagnosis. This imbalance is underscored by workforce data; according to the Royal College of Radiologists' '2023 Clinical Radiology Workforce Census Report' released in June 2024, while the UK clinical radiology workforce increased by 6% in 2023, the demand for CT and MRI reporting rose by 11%, intensifying pressure on existing staff.

Additionally, advancements in deep learning for enhanced image reconstruction are fueling market expansion by directly improving operational efficiency and patient throughput. Modern AI algorithms allow for the creation of high-fidelity images from undersampled raw data, drastically reducing the time patients spend in scanners without sacrificing diagnostic quality. This capability was highlighted in December 2024 when GE HealthCare introduced Sonic DL for 3D, a deep learning innovation that reduces MRI scan times by up to 86%. The potential for such efficiency has attracted significant capital, as seen in February 2024 when Ezra secured $21 million to accelerate the expansion of its AI-powered MRI services.

Market Challenges

The substantial capital investment necessary for deployment significantly restricts the growth of the Global AI in MRI Market. Implementing these solutions entails high costs related to purchasing software licenses and upgrading IT infrastructure to handle data-intensive workflows. These financial requirements establish a formidable barrier to entry, particularly for smaller independent clinics and healthcare systems in developing regions that operate with limited budgets. Consequently, facilities frequently delay adoption despite the potential for enhanced operational efficiency, preventing the market from achieving its full potential volume.

Recent statistics reinforce the impact of these economic constraints on the sector. Data from the European Society of Radiology in 2024 revealed that 49.5% of surveyed members cited costs or a lack of budget as the primary barrier to implementing AI in clinical practice. This suggests that financial hurdles are a leading reason for the hesitation among radiology departments to integrate these tools. Without the necessary funding to cover initial expenses, a significant portion of the market remains unable to leverage AI capabilities, thereby directly limiting overall market expansion.

Market Trends

The integration of Generative AI for Radiology Reporting is fast becoming a crucial solution to the administrative burdens straining diagnostic workflows. Moving beyond standard image analysis, this trend employs large language models to automatically draft, customize, and structure radiological reports based on image findings and radiologist dictation, thereby cutting down documentation time and reducing radiologist fatigue. The commercial viability of this technology was strongly confirmed in January 2025, when Rad AI raised $60 million in Series C funding to hasten the adoption of its generative AI reporting platform across major healthcare systems.

Concurrently, the rise of Vendor-Neutral AI App Stores is transforming how healthcare facilities acquire and deploy artificial intelligence tools. Instead of managing fragmented contracts with individual developers, hospitals are increasingly adopting centralized orchestration platforms that offer a single interface for managing diverse algorithms from multiple vendors. This consolidation strategy was emphasized in December 2025 at RSNA 2025, where DeepHealth unveiled AI Studio, an orchestration platform integrating over 140 AI algorithms from more than 75 vendors to streamline clinical deployment and governance.

Key Players Profiled in the AI in MRI Market

  • Digital Diagnostics Inc.
  • Tempus AI, Inc.
  • Advanced Micro Devices, Inc.
  • HeartFlow, Inc.
  • Enlitic, Inc.
  • Viz.ai, Inc.
  • EchoNous Inc.
  • HeartVista Inc.
  • Exo Imaging, Inc.
  • Nano-X Imaging Ltd.

Report Scope

In this report, the Global AI in MRI Market has been segmented into the following categories:

AI in MRI Market, by Clinical Application:

  • Musculoskeletal
  • Colon
  • Prostate
  • Liver
  • Cardiovascular
  • Neurology
  • Lung
  • Breast
  • Others

AI in MRI Market, by Offering Type:

  • Hardware
  • Software
  • Services

AI in MRI Market, by Technology:

  • Deep Learning
  • Machine Learning
  • Computer Vision
  • NLP
  • Speech Recognition
  • Querying Method
  • Others

AI in MRI Market, by Deployment Type:

  • On-premises
  • Cloud

AI in MRI Market, by End Use:

  • Hospitals
  • Clinics
  • Research & Laboratories
  • Others

AI in MRI Market, by Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AI in MRI Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global AI in MRI Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Clinical Application (Musculoskeletal, Colon, Prostate, Liver, Cardiovascular, Neurology, Lung, Breast, Others)
5.2.2. By Offering Type (Hardware, Software, Services)
5.2.3. By Technology (Deep Learning, Machine Learning, Computer Vision, NLP, Speech Recognition, Querying Method, Others)
5.2.4. By Deployment Type (On-premises, Cloud)
5.2.5. By End Use (Hospitals, Clinics, Research & Laboratories, Others)
5.2.6. By Region
5.2.7. By Company (2025)
5.3. Market Map
6. North America AI in MRI Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Clinical Application
6.2.2. By Offering Type
6.2.3. By Technology
6.2.4. By Deployment Type
6.2.5. By End Use
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States AI in MRI Market Outlook
6.3.2. Canada AI in MRI Market Outlook
6.3.3. Mexico AI in MRI Market Outlook
7. Europe AI in MRI Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Clinical Application
7.2.2. By Offering Type
7.2.3. By Technology
7.2.4. By Deployment Type
7.2.5. By End Use
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany AI in MRI Market Outlook
7.3.2. France AI in MRI Market Outlook
7.3.3. United Kingdom AI in MRI Market Outlook
7.3.4. Italy AI in MRI Market Outlook
7.3.5. Spain AI in MRI Market Outlook
8. Asia-Pacific AI in MRI Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Clinical Application
8.2.2. By Offering Type
8.2.3. By Technology
8.2.4. By Deployment Type
8.2.5. By End Use
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China AI in MRI Market Outlook
8.3.2. India AI in MRI Market Outlook
8.3.3. Japan AI in MRI Market Outlook
8.3.4. South Korea AI in MRI Market Outlook
8.3.5. Australia AI in MRI Market Outlook
9. Middle East & Africa AI in MRI Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Clinical Application
9.2.2. By Offering Type
9.2.3. By Technology
9.2.4. By Deployment Type
9.2.5. By End Use
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia AI in MRI Market Outlook
9.3.2. UAE AI in MRI Market Outlook
9.3.3. South Africa AI in MRI Market Outlook
10. South America AI in MRI Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Clinical Application
10.2.2. By Offering Type
10.2.3. By Technology
10.2.4. By Deployment Type
10.2.5. By End Use
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil AI in MRI Market Outlook
10.3.2. Colombia AI in MRI Market Outlook
10.3.3. Argentina AI in MRI Market Outlook
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Mergers & Acquisitions (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global AI in MRI Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Digital Diagnostics Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Tempus AI, Inc.
15.3. Advanced Micro Devices, Inc.
15.4. HeartFlow, Inc.
15.5. Enlitic, Inc.
15.6. Viz.ai, Inc.
15.7. EchoNous Inc.
15.8. HeartVista Inc.
15.9. Exo Imaging, Inc.
15.10. Nano-X Imaging Ltd.
16. Strategic Recommendations

Companies Mentioned

The key players profiled in this AI in MRI market report include:
  • Digital Diagnostics Inc.
  • Tempus AI, Inc.
  • Advanced Micro Devices, Inc.
  • HeartFlow, Inc.
  • Enlitic, Inc.
  • Viz.ai, Inc.
  • EchoNous Inc.
  • HeartVista Inc.
  • Exo Imaging, Inc.
  • Nano-X Imaging Ltd.

Table Information